-
1
Gene therapies development: slow progress and promising prospect
Published 2017-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
2
Analysis of health economics assessment reports for pharmaceuticals in France – understanding the underlying philosophy of CEESP assessment
Published 2017-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
3
Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
Published 2017-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
4
Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
Published 2017-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
5
Supply-side and demand-side policies for biosimilars: an overview in 10 European member states
Published 2017-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
6
Key drivers for market penetration of biosimilars in Europe
Published 2017-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
7
Value added medicines: what value repurposed medicines might bring to society?
Published 2017-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article